ARTICLE | Distillery Therapeutics
Therapeutics: Sphingosine 1-phosphate receptor 2 (S1PR2; S1P2; EDG5)
July 16, 2015 7:00 AM UTC
In vitro and mouse studies have identified an S1P2 inhibitor that could help treat neuroblastoma. Chemical synthesis and testing in a human cell-based assay of analogs of a research-grade S1P2 inhibit...